Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Wojnarowska

Showing results (81-90 of 289) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Dermatology|August 8, 2001
Minocycline as a therapeutic option in bullous pemphigoidW J Loo, G Kirtschig, F Wojnarowska
Journal of Cutaneous Pathology|October 1, 1986
The significance of an IgM band at the dermo-epidermal junctionF Wojnarowska, B Bhogal, M M Black
Clinical and Experimental Dermatology|June 24, 2010
Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?A R Shipman, S Cooper, F Wojnarowska
The Australasian Journal of Dermatology|December 6, 2000
Mixed immunobullous disease: is this linear IgA disease?A T Sheridan, G Kirtschig, F Wojnarowska
The Australasian Journal of Dermatology|May 1, 1996
Minocycline is a useful adjuvant therapy for pemphigusZ S Gaspar, V Walkden, F Wojnarowska
Clinical and Experimental Dermatology|June 21, 2012
Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature reviewA R Shipman, H Reddy, F Wojnarowska
The Journal of Physiology|December 1, 1972
Oligopeptidases of brush border membranes of rat small intestinal mucosal cellsM Fujita, D S Parsons, F Wojnarowska
Clinical and Experimental Dermatology|January 1, 1991
Chronic bullous disease of childhood with oral mucosal scarringS Edwards, F Wojnarowska, L M Armstrong
The British Journal of Dermatology|May 1, 1992
Absence of expression of class II major histocompatibility complex determinants on keratinocytes in bullous pemphigoidV A Venning, D Dean, F Wojnarowska
International Journal of Dermatology|February 1, 1991
Cutaneous problems with drug therapy in rheumatoid arthritisC L Wilson, A Bradlow, F Wojnarowska
Pageof 29

Showing results (81-90 of 289) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Dermatology|August 8, 2001
Minocycline as a therapeutic option in bullous pemphigoidW J Loo, G Kirtschig, F Wojnarowska
Journal of Cutaneous Pathology|October 1, 1986
The significance of an IgM band at the dermo-epidermal junctionF Wojnarowska, B Bhogal, M M Black
Clinical and Experimental Dermatology|June 24, 2010
Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?A R Shipman, S Cooper, F Wojnarowska
The Australasian Journal of Dermatology|December 6, 2000
Mixed immunobullous disease: is this linear IgA disease?A T Sheridan, G Kirtschig, F Wojnarowska
The Australasian Journal of Dermatology|May 1, 1996
Minocycline is a useful adjuvant therapy for pemphigusZ S Gaspar, V Walkden, F Wojnarowska
Clinical and Experimental Dermatology|June 21, 2012
Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature reviewA R Shipman, H Reddy, F Wojnarowska
The Journal of Physiology|December 1, 1972
Oligopeptidases of brush border membranes of rat small intestinal mucosal cellsM Fujita, D S Parsons, F Wojnarowska
Clinical and Experimental Dermatology|January 1, 1991
Chronic bullous disease of childhood with oral mucosal scarringS Edwards, F Wojnarowska, L M Armstrong
The British Journal of Dermatology|May 1, 1992
Absence of expression of class II major histocompatibility complex determinants on keratinocytes in bullous pemphigoidV A Venning, D Dean, F Wojnarowska
International Journal of Dermatology|February 1, 1991
Cutaneous problems with drug therapy in rheumatoid arthritisC L Wilson, A Bradlow, F Wojnarowska
Pageof 29